ProPhase Labs, Inc. Quarterly report pursuant to Section 13 or 15(d)

Quarterly report pursuant to Section 13 or 15(d)

Transactions Affecting Stockholders' Equity (Details Narrative)

Transactions Affecting Stockholders' Equity (Details Narrative)							3 Months Ended		9 Months Ended
	Sep. 15, 2020 $ / shares shares	Dec. 12, 2019 $ / shares	Jan. 24, 2019 USD ($) $ / shares	Dec. 24, 2018 $ / shares	Sep. 05, 2018 $ / shares	Apr. 12, 2018 USD ($) $ / shares shares	Sep. 30, 2020 USD ($) $ / shares shares	Sep. 30, 2019 shares	Sep. 30, 2020 USD ($) $ / shares shares	Sep. 30, 2019 USD ($) shares	Dec. 31, 2019 $ / shares shares	May 05, 2010 shares
Common stock, shares authorized							50,000,000		50,000,000		50,000,000
Common stock, par value \| $ / shares							$ 0.0005		$ 0.0005		$ 0.0005
Preferred stock, shares authorized							1,000,000		1,000,000		1,000,000
Preferred stock, par value \| $ / shares							$ 0.0005		$ 0.0005		$ 0.0005
Preferred stock, shares issued
Cash dividend, per shares \| $ / shares				$ 0.25
Payments of dividends \| $										$ 2,929,000
Share based compensation \| $									$ 669,000
Stock options weighted average period									1 year 7 months 6 days
2010 Directors' Equity Compensation Plan [Member]
Plan provides total number of shares of common stock issued												675,000
Stock option granted							212,605	4,727	230,660	15,464
Director fees \| $									$ 108,000	$ 45,000
Stock issued during period shares									200,000
2010 Equity Compensation Plan [Member]
Plan provides total number of shares of common stock issued												3,900,000
Stock option granted							250,000		250,000
Stock option exercised
Options outstanding - shares							1,032,000		1,032,000
Available for grant, shares							278,659		278,659
2018 Stock Incentive Plan [Member]
Stock option granted						2,300,000
Share based compensation \| $						$ 188,000
Stock options weighted average period						4 months 24 days
Stock option exercise price per share \| $ / shares						$ 3.00
Stock option exercisable						36 months
2018 Stock Plan [Member] \| CEO Option [Member]
Stock option exercise price per share \| $ / shares		$ 1.50	$ 1.75		$ 2.00
Stock option plan, reduced exercise price per share, description		The exercise price of the CEO Option was further reduced from $1.75 to $1.50 per share, effective as of December 12, 2019,	The exercise price of the CEO Option was further reduced from $2.00 to $1.75 per share.		Exercise price of the CEO Option was reduced from $3.00 per share to $2.00 per share.
2018 Stock Plan [Member] \| CEO Option [Member] \| Stock Holders [Member]
Cash dividend, per shares \| $ / shares		$ 0.25	$ 0.25		$ 1.00
Common Stock [Member]
Payments of dividends \| $			$ 2,900,000
Common Stock [Member] \| 2010 Directors' Equity Compensation Plan [Member]
Stock issued during period shares									128,126
Warrant [Member]
Stock issued during period shares	200,000
Share based compensation \| $							$ 16,000		$ 16,000
Warrants exercise price per share \| $ / shares	$ 3
Warrants outstanding shares							400,000		400,000
Fair value of warrants \| $									$ 372,000
Expected term of warrants	2 years
Warrant [Member] \| Weighted Average Risk Rate [Member]
Measurement input in determining fair value	0.16
Warrant [Member] \| Dividend Yield [Member]
Measurement input in determining fair value	0
Warrant [Member] \| Expected Volatility [Member]
Measurement input in determining fair value	56.21